FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 175 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $4,149,000 | +3166.9% | 110,134 | +1378.7% | 0.00% | – |
Q4 2020 | $127,000 | +2016.7% | 7,448 | +449.7% | 0.00% | – |
Q3 2020 | $6,000 | -75.0% | 1,355 | -64.9% | 0.00% | – |
Q2 2020 | $24,000 | +4.3% | 3,865 | -62.5% | 0.00% | – |
Q1 2020 | $23,000 | -25.8% | 10,293 | +50.3% | 0.00% | – |
Q4 2019 | $31,000 | -77.7% | 6,848 | -80.8% | 0.00% | – |
Q3 2019 | $139,000 | +25.2% | 35,750 | +94.1% | 0.00% | – |
Q2 2019 | $111,000 | -38.3% | 18,414 | +36.9% | 0.00% | – |
Q1 2019 | $180,000 | -86.2% | 13,451 | -90.4% | 0.00% | -100.0% |
Q4 2018 | $1,301,000 | +74.6% | 139,875 | +161.3% | 0.00% | 0.0% |
Q3 2018 | $745,000 | +138.0% | 53,528 | +170.5% | 0.00% | – |
Q2 2018 | $313,000 | -13.5% | 19,787 | -6.0% | 0.00% | – |
Q1 2018 | $362,000 | -81.8% | 21,053 | -76.8% | 0.00% | -100.0% |
Q4 2017 | $1,987,000 | +89.4% | 90,667 | +253.7% | 0.00% | 0.0% |
Q3 2017 | $1,049,000 | -24.6% | 25,632 | -44.6% | 0.00% | 0.0% |
Q2 2017 | $1,392,000 | +19.3% | 46,231 | +43.3% | 0.00% | 0.0% |
Q1 2017 | $1,167,000 | -77.3% | 32,272 | -68.6% | 0.00% | -80.0% |
Q4 2016 | $5,145,000 | +511.0% | 102,668 | +540.3% | 0.01% | +400.0% |
Q3 2016 | $842,000 | +108.9% | 16,035 | +64.4% | 0.00% | – |
Q2 2016 | $403,000 | -58.5% | 9,752 | -59.2% | 0.00% | -100.0% |
Q1 2016 | $970,000 | +108.6% | 23,886 | +113.5% | 0.00% | – |
Q4 2015 | $465,000 | -22.8% | 11,188 | -71.4% | 0.00% | -100.0% |
Q3 2015 | $602,000 | +81.9% | 39,106 | +193.5% | 0.00% | – |
Q2 2015 | $331,000 | -83.9% | 13,323 | -85.2% | 0.00% | -100.0% |
Q1 2015 | $2,058,000 | +433.2% | 90,059 | +530.1% | 0.00% | – |
Q4 2014 | $386,000 | +343.7% | 14,292 | +92.5% | 0.00% | – |
Q3 2014 | $87,000 | -42.8% | 7,425 | -24.2% | 0.00% | – |
Q2 2014 | $152,000 | -27.6% | 9,794 | -8.2% | 0.00% | – |
Q1 2014 | $210,000 | +356.5% | 10,669 | +292.4% | 0.00% | – |
Q4 2013 | $46,000 | – | 2,719 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|